Early Lung Cancer: Diagnosis and Treatment

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Pulmonary".

Deadline for manuscript submissions: 30 June 2024 | Viewed by 776

Special Issue Editors


E-Mail Website
Guest Editor
Department of Chest Surgery, St. Marianna University School of Medicine, Kawasaki, Japan
Interests: lung cancer; thoracic disease; minimally invasive surgery; perioperative management

E-Mail Website
Guest Editor
Department of Chest Surgery, St. Marianna University School of Medicine, Kawasaki, Japan
Interests: lung cancer; thoracic disease

Special Issue Information

Dear Colleagues,

The widespread use of CT scans has revolutionized the early detection of lung cancer. This shift has not only led to a paradigm change in treatment approaches—from traditional lobectomy to segmentectomy or partial resection—but also witnessed advancements in high-performance radiotherapy techniques.

Our Special Issue aims to comprehensively explore various facets of early-stage lung cancer. From diagnostics to surgical and radiotherapeutic interventions, we seek to delve into topics such as treatment modalities, extent of lung resections, surgical approaches and intraoperative techniques for identifying small lung cancers.

The Special Issue will feature cutting-edge research, highlighting the latest advancements in the diagnosis and treatment of early-stage lung cancer. From innovative diagnostic tools to state-of-the-art surgical and radiotherapy technologies, we aim to showcase the forefront of scientific progress in this field.

We invite submissions covering a broad spectrum of themes related to early-stage lung cancer, including, but not limited to, diagnostic methods, medical checkup, surgical and radiotherapeutic therapy, extent of lung resection, intraoperative identification of small lung cancers. Researchers and practitioners are encouraged to contribute their insights to advance our understanding and treatment of this critical health issue.

Dr. Takahiro Homma
Dr. Hideki Marushima
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • lung cancer
  • diagnosis
  • thoracic surgery
  • robot-assisted thoracoscopic surgery
  • video-assisted thoracoscopic surgery
  • lung resection
  • segmentectomy
  • radiation therapy
  • navigation
  • computed tomography

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

12 pages, 3727 KiB  
Article
Correlation between Radiological Characteristics, PET-CT and Histological Subtypes of Primary Lung Adenocarcinoma—A 102 Case Series Analysis
by Nikola Colic, Ruza Stevic, Mihailo Stjepanovic, Milan Savić, Jelena Jankovic, Slobodan Belic, Jelena Petrovic, Nikola Bogosavljevic, Dejan Aleksandric, Katarina Lukic, Marko Kostić, Dusan Saponjski, Jelena Vasic Madzarevic, Stefan Stojkovic, Maja Ercegovac and Zeljko Garabinovic
Medicina 2024, 60(4), 617; https://doi.org/10.3390/medicina60040617 - 10 Apr 2024
Viewed by 650
Abstract
Background and Objectives: Lung cancer is the second most common form of cancer in the world for both men and women as well as the most common cause of cancer-related deaths worldwide. The aim of this study is to summarize the radiological characteristics [...] Read more.
Background and Objectives: Lung cancer is the second most common form of cancer in the world for both men and women as well as the most common cause of cancer-related deaths worldwide. The aim of this study is to summarize the radiological characteristics between primary lung adenocarcinoma subtypes and to correlate them with FDG uptake on PET-CT. Materials and Methods: This retrospective study included 102 patients with pathohistologically confirmed lung adenocarcinoma. A PET-CT examination was performed on some of the patients and the values of SUVmax were also correlated with the histological and morphological characteristics of the masses in the lungs. Results: The results of this analysis showed that the mean size of AIS-MIA (adenocarcinoma in situ and minimally invasive adenocarcinoma) cancer was significantly lower than for all other cancer types, while the mean size of the acinar cancer was smaller than in the solid type of cancer. Metastases were significantly more frequent in solid adenocarcinoma than in acinar, lepidic, and AIS-MIA cancer subtypes. The maximum standardized FDG uptake was significantly lower in AIS-MIA than in all other cancer types and in the acinar predominant subtype compared to solid cancer. Papillary predominant adenocarcinoma had higher odds of developing contralateral lymph node involvement compared to other types. Solid adenocarcinoma was associated with higher odds of having metastases and with higher SUVmax. AIS-MIA was associated with lower odds of one unit increase in tumor size and ipsilateral lymph node involvement. Conclusions: The correlation between histopathological and radiological findings is crucial for accurate diagnosis and staging. By integrating both sets of data, clinicians can enhance diagnostic accuracy and determine the optimal treatment plan. Full article
(This article belongs to the Special Issue Early Lung Cancer: Diagnosis and Treatment)
Show Figures

Figure 1

Back to TopTop